Referencias

  1. Bentin T, Nielsen PE. In vitro transcription of a torsionally constrained template. Nucleic Acids Res. 2002 Feb 1;30(3):803-9.
  2. Bunnell BA, Morgan RA. Gene therapy for infectious diseases. Clin Microbiol Rev. 1998 Jan;11(1):42-56.
  3. Chan PP, Glazer PM. Triplex DNA: fundamentals, advances, and potential applications for gene therapy.
  4. Cottrell TR, Doering TL. Silence of the strands: RNA interference in eukaryotic pathogens. Trends Microbiol. 2003 Jan; 11(1):37-43.
  5. Dagle JM, Weeks DL. Oligonucleotide-based strategies to reduce gene expression. Differentiation. 2001 Dec;69(2-3):75-82.
  6. Demidov VV, Frank-Kamenetskii MD. Sequence-specific targeting of duplex DNA by peptide nucleic acids via triplex strand invasion. Methods. 2001 Feb;23(2):108-22.
  7. Diviacco S, Rapozzi V, Xodo L, Helene C, Quadrifoglio F, Giovannangeli C. Site-directed inhibition of DNA replication by triple helix formation. FASEB J. 2001 Dec;15(14):2660-8.
  8. Duval-Valentin G, Thuong NT, Helene C. Specific inhibition of transcription by triple helix-forming oligonucleotides. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):504-8.
  9. Faria M, Giovannangeli C. Triplex-forming molecules: from concepts to applications. J Gene Med. 2001 Jul-Aug;3(4):299-310.
  10. Fjose A, Ellingsen S, Wargelius A, Seo HC. RNA interference: mechanisms and applications. Biotechnol Annu Rev. 2001; 7:31-57.
  11. Giovannangeli C, Helene C. Triplex technology takes off. Nat Biotechnol. 2000 Dec;18(12):1245-6.
  12. Good L, Nielsen PE. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci U S A. 1998 Mar 3; 95(5):2073-6.
  13. Good L, Nielsen PE. Peptide nucleic acid (PNA) antisense effects in Escherichia coli. Curr Issues Mol Biol. 1999;1(1-2):111-6.
  14. Gowers DM, Fox KR. Towards mixed sequence recognition by triple helix formation. Nucleic Acids Res. 1999 Apr 1;27(7):1569-77. J Mol Med. 1997 Apr;75(4):267-82.
  15. Kochetkova M, Shannon MF. Triplex-forming oligonucleotides and their use in the analysis of gene transcription. Methods Mol Biol. 2000;130:189-201.
  16. Lacroix L, Arimondo PB, Takasugi M, Helene C, Mergny JL. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions. Biochem Biophys Res Commun. 2000 Apr 13;270(2):363-9.
  17. Lavrovsky Y, Chen S, Roy AK. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes. Biochem Mol Med. 1997 Oct;62(1):11-22.
  18. Liu MA. DNA vaccines: a review.J Intern Med. 2003 Apr;253(4):402-10.
  19. Majumdar A, Khorlin A, Dyatkina N, Lin FL, Powell J, Liu J, Fei Z, Khripine Y, Watanabe KA, George J, Glazer PM, Seidman MM. Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet. 1998 Oct;20(2):212-4.
  20. Merril CR, Scholl D, Adhya SL. Timeline: The prospect for bacteriophage therapy in Western medicine.Nat Rev Drug Discov. 2003 Jun;2(6):489-97.
  21. Molling K. Naked DNA for vaccine or therapy. J Mol Med. 1997 Apr;75(4):242-6.
  22. Nielsen PE, Egholm M. An introduction to peptide nucleic acid. Curr Issues Mol Biol. 1999;1(1-2):89-104.
  23. Praseuth D, Guieysse AL, Helene C. Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim Biophys Acta. 1999 Dec 10;1489(1):181-206.
  24. Shuey DJ, McCallus DE, Giordano T. RNAi: gene-silencing in therapeutic intervention. Drug Discov Today. 2002 Oct 15; 7(20):1040-6.
  25. Strugnell RA, Drew D, Mercieca J, DiNatale S, Firez N, Dunstan SJ, Simmons CP, Vadolas J. DNA vaccines for bacterial infections. Immunol Cell Biol. 1997 Aug;75(4):364-9.
  26. Sweeney R, Fan Q, Yao MC. Antisense ribosomes: rRNA as a vehicle for antisense RNAs. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8518-23.
  27. Vasquez KM, Glazer PM. Triplex-forming oligonucleotides: principles and applications. Q Rev Biophys. 2002 Feb;35(1):89-107.
  28. Wagner EG, Simons RW. Antisense RNA control in bacteria, phages, and plasmids. Annu Rev Microbiol. 1994;48:713-42.
  29. Wahlestedt C, Salmi P, Good L, Kela J, Johnsson T, Hokfelt T, Broberger C, Porreca F, Lai J, Ren K, Ossipov M, Koshkin A, Jakobsen N, Skouv J, Oerum H, Jacobsen MH, Wengel J. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5633-8.